NAD+ levels naturally decline with age and stress, making replenishment beneficial for cellular health and brain function
Since these compounded medications are altered to be copycats, they may contain contaminants or impurities, inconsistent amounts of active ingredients, incorrect dosages, and even incorrect ingredients, leaving patients vulnerable to a variety of adverse effects
Regulatory status: BPC-157 is not an approved human medicinal product in any regulatory zone (FDA, EMA, KL)
It is one of the most abundant phospholipids in the human body and a primary component of every cell membrane
References Bennardo, L., Passante, M., Cameli, N., Cristaudo, A., Patruno, C., Nistic, S
BPC-157 is still in the early stages of research, with much of the data coming from animal studies rather than human clinical trials